Skip to main content
. 2015 Nov 4;32(5):650–656. doi: 10.1093/bioinformatics/btv650

Table 1.

Genome-wide real data evaluation based on false-positive rate (FPR), false discovery rate (FDR) and recover rate (RR)

Dataset Method FPR (%) FDR (%) RR (%)
IMR90 HMRF-Bayesian 0.52 15.60 42.30
IMR90 AFC 0.60 18.40 41.10
IMR90 Fit-Hi-C 0.64 19.20 41.20
IMR90 + TNF-α HMRF-Bayesian 0.83 18.50 55.40
IMR90 + TNF-α AFC 0.98 22.40 52.90
IMR90 + TNF-α Fit-Hi-C 1.00 22.50 53.30
Dataset Method FPR FDR RR

Split1 HMRF 0.84 19.10 55.90
Split1 AFC 0.97 22.60 54.00
Split1 Fit-Hi-C 1.03 23.50 53.70
Split2 HMRF 0.47 15.20 41.30
Split2 AFC 0.56 18.60 39.90
Split2 Fit-Hi-C 0.58 18.80 40.30

Assuming calling result for the combined dataset is the true peak pattern, we summarized the following measures for 1432 domains, i.e. genome-wide. We reported the genome-wide average of false-positive rate (FPR), false discovery rate (FDR) and recovery rate (RR) by the HMRF-Bayesian method, AFC method and Fit-Hi-C for both IMR90 before TNF-α treatment and IMR90 after TNF-α treatment. We found that the HMRF-Bayesian method has better performance than AFC method and Fit-Hi-C